Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Archer Limited: Q4 2020 trading update and 2021 financial outlook

Hamilton, Bermuda (January 28, 2021) Archer will today host an analyst call where we will share our preliminary financials for Q4 2020 and our outlook for 2021. Trading update Q4 2020 Based on preliminary unaudited financials, Archer Limited expects to report the following key financials for Q4 2020: · Revenue of $211 million was up 15% compared to third quarter · EBITDA reported of $19.2 million was up 23% compared to third quarter · EBITDA before exceptional items of $23.3 million · Net interest bearing debt of $504 million · Robust liquidity of $110 million

Interim report for the fourth quarter and full-year 2020

NCC delivers steady progress“NCC’s project portfolio has improved, which is reflected in our earnings. During this quarter, we also took measures to strengthen our industrial operations,” says Tomas Carlsson, President and CEO of NCC. · The contracting business has steady progress. Improved operating profit, healthy orders received and strong order backlog in Building Sweden and Building Nordics. Somewhat lower orders received in Infrastructure due to more early involvement projects and a lower tender outcome · The plan for improved earnings in the Industry business area that was

Understanding how genetic motifs conduct "the music of life"

Our genetic codes control not only which proteins our cells produce, but also – to a great extent – in what quantity. This ground-breaking discovery, applicable to all biological life, was recently made by systems biologists at Chalmers University of Technology, Sweden, using supercomputers and artificial intelligence. Their research, which could also shed new light on the mysteries of cancer, was recently published in the scientific journal Nature Communications. DNA molecules contain instructions for cells for producing various proteins. This has been known since the middle

Invitation to presentation of Orkla’s fourth quarter 2020 results, Thursday 11 February

Orkla will report its fourth quarter 2020 results on Thursday, 11 February 2021 at 7.00 a.m. CET.The quarterly report and the presentation material will be available at this time at: https://investors.orkla.com.The results will be presented in a webcast with Presidet & CEO Jaan Ivar Semlitsch and CFO Harald Ullevoldsæter at 8.00 a.m. CET. As a consequence of the Corona situation, there will not be a physical presentation of the results.The presentation and subsequent Q&A session will be held in English and may be viewed live at https://investors.orkla.com (direct link: https://events.

Year-end announcement 2020

· Highly resilient performance in Q4, despite challenging operating conditions · Credit Management Services positioned for growth with strong sales and record pipeline · Strong cash returns in recovering Strategic Markets · Impressive performance in Portfolio Investments, investment levels at replenishment rate with attractive returns · Accelerating towards ONE IntrumFourth quarter, October-December 2020 · Cash Revenues amounted to SEK 5,601 M (5,751).  · Cash EBITDA amounted to SEK 3,124 M (3,063). · Cash EBIT amounted to SEK 1,523 M (1,419).  · Cash RoIC was 8.7

Michael Ladurner appointed Chief Financial Officer of Intrum

Michael Ladurner has been appointed Chief Financial Officer (CFO) of Intrum. Ladurner has been acting CFO since October 2020. He joined the Group in 2016 and has had roles as Business Development Director for Portfolio Investments and Group Strategy and Analytics Director. Michael Ladurner takes on the CFO role from today, 28 January 2021. He will be reporting directly to President & CEO Anders Engdahl and be a part of the Group Management Team. For further information, please contact:Anna Fall, Chief Brand & Communications Officer+46 (0)709 96 98 21anna.fall@intrum.com This

Year-end Report January – December 2020

“TF Bank’s loan portfolio increased by 8% in local currencies during the fourth quarter. Nordic risk and the credit card initiative in Germany have been prioritised. For consumer loans in Norway and Finland, we soon intend to sign new agreements for continuing sales of past due loans, which provides comfort and predictability for the future. Overall, TF Bank is well positioned to continue expanding during 2021.” – Mattias Carlsson, CEOOctober – December 2020 compared with October – December 2019 · The loan portfolio amounted to SEK 7,922 million, the increase in local currencies was 8 %

Kungsleden divests residential building rights in Västerås

Kungsleden has signed an agreement with JM AB to divest the Västerås Isolatorn 12 property with future residential building rights at a price, before deductions, of SEK 4,100/sq.m. GTA.The property currently comprises approximately 12,000 sq.m. of vacant industrial buildings. Kungsleden has successfully pursued a zoning plan process to transform the property into an attractive residential area. The new zoning plan, which is under review, would allow residential housing of about 36,000 sq.m. GTA and a preschool of 1,000 sq.m. GTA. The purchaser assumes responsibility for soil remediation and

JM acquiring building rights for development of 400 residential units in Västerås

JM has signed an agreement with Kungsleden AB to acquire the property Västerås Isolatorn 12. The deal is worth approximately SEK 120 million. Occupancy and payment will take place after the detailed plan has gained legal force, which is estimated to occur in Q2 2021.The detailed plan is expected to allow the development of around 400 residential units and potentially a preschool. This acquisition gives JM access to an attractive development area in Emaus, Västerås. The acquisition will be reported within the JM Residential Sweden business segment, East Region, in Q2 2021. “The property

2020 Corruption Perceptions Index reveals widespread corruption is weakening COVID-19 response, threatening global recovery

The 2020 Corruption Perceptions Index  (CPI) released today by Transparency International reveals that persistent corruption is undermining health care systems and contributing to democratic backsliding amid the COVID-19 pandemic.Countries that perform well on the index invest more in health care, are better able to provide universal health coverage and are less likely to violate democratic norms and institutions or the rule of law.   “COVID-19 is not just a health and economic crisis. It is a corruption crisis. And one that we are currently failing to

RNB RETAIL AND BRANDS AB (PUBL) instigates a written procedure in order to waive certain provisions in the Terms and Conditions of its outstanding senior secured notes

RNB RETAIL AND BRANDS AB (publ) (the "Company") instigates a written procedure (the "Written Procedure") for the notes with ISIN SE0010625830 (the "Notes") in order to waive certain provisions in the terms and conditions of the Notes (the "Terms and Conditions"). Earlier today, the Company announced, by way of a press release, that it has reached an agreement with NK Retail AB for the sale of the assets in Departments & Stores for a preliminary value of SEK 58 million (the "Transaction"). The Transaction is expected to close on 3 February 2021, subject to the approval from the holders of

Handicare announces preliminary financial results for the fourth quarter 2020 and an outlook for 2021

As a result of Savaria Corporation ("Savaria") today having announced a public cash offer for Handicare Group AB (“Handicare” or the “Company”), Handicare announces certain preliminary financial information in respect of the fourth quarter 2020 and an outlook for 2021.Revenues for the quarter are anticipated at EUR 59.2 million, compared to EUR 58.5[[1]] million for the corresponding period in 2019 resulting in an organic growth of 5.6% (currency adjusted). Revenues in Handicare’s key focus area, Accessibility, is anticipated at EUR 43.8 million, compared to EUR 40.2 million for the

Statement from the Board of Handicare Group AB in relation to the public cash offer by Savaria (Sweden) AB

Conclusion The Board of Handicare unanimously recommends the shareholders of Handicare to accept the offer by Savaria. “Based on an assessment of Handicare’s present position, the expected future development of the company as well as related opportunities and risks, the Board of Directors considers that the immediate rewards of the offer reflect Handicare's long-term future prospects. Therefore, the Board has decided to unanimously recommend the offer. In addition, the Board also recognizes that the major owner Nordic Capital Fund VII, being a long-term shareholder in Handicare with

Simon-Kucher on a Steady Growth Path

The management consultancy, which has seven US offices, continues to grow despite the difficult economic year. New partners strengthen the company’s expertise, particularly in the Life Sciences division. In addition, the consultancy is planning to establish its own software venture.[Boston, MA], [Jan. 27, 2021] – The global strategy and marketing consultancy Simon-Kucher & Partners  ended the 2020 financial year with an annual revenue of 406.2 million US dollars. This equals a growth rate of one percent compared to the previous year, with the Life Sciences

Q-Free: Acceptances received under mandatory offer to acquire all shares in Q-Free ASA

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, any jurisdiction in which the making of the Offer, the distribution of this stock exchange announcement or the acceptance of any tender of shares would contravene applicable laws or regulations. (Oslo, 27 January 2021): Reference is made to the mandatory offer (the “Offer”) from Rieber & Søn AS (the “Offeror”) to acquire all shares in Q-Free ASA (“Q-Free” or the “Company”) pursuant to an offer document

Per Bertland to step down as CEO of Beijer Ref during 2021

Per Bertland has today informed Beijer Ref’ AB:s (publ) Board of Directors that he plans to step down as CEO. The transition will take place when a successor has been found or during the latter part of 2021 at the latest. Per intends to remain active within Beijer Ref by making himself available to join the Board of Directors, if supported by the shareholders. Beijer Ref’s largest shareholder, EQT Private Equity, has expressed its intention to call for a general meeting whereby they will nominate Per as a member of the Board of Directors. Bernt Ingman, Chairman of the Board of Directors,

Alligator Bioscience’s rights issue oversubscribed

Alligator Bioscience AB (publ) (“Alligator” or the “Company”) has completed the share issue with pre-emption rights for the Company’s shareholders, which was resolved upon by the Board of Directors on December 15, 2020 pursuant to the authorization from the annual general meeting on May 5, 2020 (the “Rights Issue”). The subscription period ran from and including January 11, 2021 to and including January 25, 2021. Through the Rights Issue, Alligator receives approximately SEK 86 million before deduction of issue costs. 13 895 925 shares, corresponding to approximately 97 per cent of the Rights

Submission deadline of the E1|R1 Photo Award extended until mid-March

Third edition of the amateur photo competition along the E1 and R1 long-distance trails calls on Europe's hikers and cyclists to send in their entriesThe third edition of the E1|R1 Photo Award, organized by Lippe Tourismus und Marketing GmbH (LTM), Detmold, has been running since October 15. Even under difficult corona conditions, the European hiking and photo community shows what it is made of with strong motifs from all over Europe. Nevertheless, the competition is also feeling the effects of the ongoing Corona pandemic. "In demand this particular year are the national hikers and cyclists

Surgical Science completes the acquisition of Mimic Technologies

Surgical Science Sweden AB (publ) announced on January 20, 2021 that a conditional agreement to acquire all shares outstanding of Mimic Technologies Inc. (“Mimic”) with operations within the robotic surgery segment had been entered into. Mimic is based in Seattle, USA and through the acquisition Surgical Science further expands its customer base within the robotic surgery segment, gains access to technology for data collection/advanced analytics and strengthens its footprint in the highly important American market. Surgical Science Sweden AB (publ) today, after all conditions precedent

Communiqué from the Extraordinary General Meeting of BoMill AB (publ)

In accordance with the Board of Directors’ proposal, the Extraordinary General Meeting in BoMill AB (publ) on January 27, 2021 resolved on a directed issue of 330,000 warrants, whereupon the company’s share capital may be increased by maximum SEK 330,000.The warrants shall entitle rights for officers of the company, founder and Member of the Board Bo Löfqvist (205 000 warrants) and Managing Director Andreas Jeppsson (125 000 warrants), to subscribe for new shares in the company according to the following.  The warrants will be issued against payment where the subscription price shall be

Result update Q4, full year 2020 and the board of directors’ dividend proposal - Regulatory information

Preliminary numbers indicate very strong growth for ADDvise Group during the fourth quarter for 2020, which will be substantially better than last year. ADDvise Group considers this to be above market expectations. With a more normalized market, an increase of ADDvise’s own products and margins, and a continued control of costs; EBITDA has increased as a result in the fourth quarter 2020. The net sales and EBITDA result 2020 will be ADDvise Group’s strongest so far. · The EBITDA result of the fourth quarter 2020 is estimated to approximately SEK 15.9 million (9.6), corresponding to an

Attana has published the company presentation given on Biotech Showcase™ 2021

The conference this year took place in digital form between January 11 to January 15. During the conference Attana broadcasted a 25-minute presentation, which is now published on Attana’s website and Youtube channel. In addition to the presentation, Attana had several rewarding meetings with potential customers that the company will follow up on. The recorded presentation can be found here .

Stayble publishes prospectus in connection with the forthcoming rights issue

Stayble Therapeutics AB (”Stayble” or the ”Company”) hereby publishes prospectus in connection with the Company’s forthcoming rights issue, with a subscription period that begins Wednesday, 3 February 2021. The prospectus has today been approved and registered by the Swedish Financial Supervisory Authority and will be available on their website (www.fi.se). The prospectus is also available on the websites of the Company (www.staybletherapeutics.se), Sedermera Fondkommission (www.sedermera.se) and Nordic Issuing (www.nordic-issuing.se). Teaser and subscription forms will be published on the

AKER ASA: Aker Horizons – Contemplated private placement and convertible bond issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Reference is made to the previous stock exchange announcement made by Aker ASA ("Aker") on 19 January 2021 regarding the acquisition of Mainstream Renewable Power (the “Acquisition”), a private placement (the “Private Placement”) and a listing on Euronext Growth Oslo (the “Listing”, and together with the Private Placement, the "IPO") of Aker

There are no items matching the current filter
There are no more items matching the current filter
Back to top